Detalhe da pesquisa
1.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652353
2.
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med
; 388(7): 621-634, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791162
3.
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Nature
; 586(7830): 589-593, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785213
4.
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med
; 386(20): 1910-1921, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320659
5.
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med
; 386(1): 35-46, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752019
6.
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
J Infect Dis
; 229(2): 367-375, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531657
7.
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med
; 385(3): 239-250, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043894
8.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med
; 385(19): 1761-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525277
9.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med
; 383(27): 2603-2615, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301246
10.
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
N Engl J Med
; 383(25): 2439-2450, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053279
11.
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Nature
; 590(7844): E26, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469216
12.
Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status Among Patients Treated in US Hospitals: 2009-2016.
Clin Infect Dis
; 73(4): 565-574, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420788
13.
Persistence of Disparities Among Racially/Ethnically Marginalized Groups in the Coronavirus Disease 2019 Pandemic Regardless of Statewide Shelter-in-Place Policies: An Analysis From Northern California.
Am J Epidemiol
; 190(11): 2300-2313, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215866
14.
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
N Engl J Med
; 385(17): 1627-1629, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525276
15.
Racial and Ethnic Disparities in Opioid Prescribing for Long Bone Fractures at Discharge From the Emergency Department: A Cross-sectional Analysis of 22 Centers From a Health Care Delivery System in Northern California.
Ann Emerg Med
; 74(5): 622-631, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272820
16.
Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance.
Clin Chem
; 62(9): 1220-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27440512
17.
An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.
Clin Infect Dis
; 58(9): 1230-40, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24519873
18.
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
Lancet
; 381(9871): 1021-8, 2013 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391465
19.
Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
Vaccine
; 42(13): 3180-3189, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614954
20.
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age.
Vaccine
; 41(50): 7548-7559, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977942